Director at Orthofix (OFIX) awarded 14,965 deferred stock units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Orthofix Medical Inc. director Vickie L. Capps received a grant of 14,965 deferred stock units of common stock on the grant date. The award vests in full on the first anniversary of the grant, contingent on continued board service, and each unit represents the right to one share.
After this grant, Capps directly holds 43,300 shares and deferred stock units in total, including 21,934 previously reported deferred stock units and 750 shares acquired under Orthofix's Stock Purchase Plan. Vested deferred stock units will convert into common stock within 45 days after her service with Orthofix ends.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
CAPPS VICKIE L
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 14,965 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 43,300 shares (Direct, null)
Footnotes (1)
- Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. Includes 21,934 previously reported deferred stock units and 750 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Key Figures
Deferred stock unit grant: 14,965 units
Post-transaction holdings: 43,300 shares/units
Previously reported DSUs: 21,934 units
+4 more
7 metrics
Deferred stock unit grant
14,965 units
Award of deferred stock units to director on grant date
Post-transaction holdings
43,300 shares/units
Total direct and deferred Orthofix common stock after grant
Previously reported DSUs
21,934 units
Deferred stock units reported before current grant and still held
SPP shares
750 shares
Shares acquired under Orthofix's Stock Purchase Plan on April 30, 2026
Grant vesting period
1 year
Deferred stock units vest on first anniversary of grant date
Settlement window after service
within 45 days
Vested deferred stock units convert to common stock after service ends
Grant price per share
$0.0000
No cash price; equity award classified as grant/acquisition
Key Terms
deferred stock units, Orthofix's Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b)
4 terms
deferred stock units financial
"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Orthofix's Stock Purchase Plan financial
"Includes 21,934 previously reported deferred stock units and 750 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 4/30/2026"
Rule 16b-3(b)(5) regulatory
"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)"
Section 16(b) regulatory
"share acquisitions under the plan are exempt from Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
FAQ
What insider transaction did Orthofix (OFIX) report for Vickie L. Capps?
Orthofix reported that director Vickie L. Capps received 14,965 deferred stock units of common stock as a grant. These units are compensation, not an open-market purchase, and increase her total direct and deferred holdings to 43,300 Orthofix common shares and units combined.
How do the 14,965 deferred stock units granted to Orthofix director Capps vest?
The 14,965 deferred stock units granted to director Vickie L. Capps vest in full on the first anniversary of the grant date. Vesting is conditioned on her continued service with Orthofix through that date, meaning she must remain in her director role to receive the full benefit.
What is the total Orthofix (OFIX) position held by director Vickie L. Capps after this Form 4?
After this award, director Vickie L. Capps directly holds 43,300 Orthofix common shares and deferred stock units. This figure includes the new 14,965-unit grant, 21,934 previously reported deferred stock units, and 750 shares acquired through Orthofix's Stock Purchase Plan earlier in 2026.
When will Vickie L. Capps’ Orthofix deferred stock units convert into common stock?
Vested deferred stock units for Vickie L. Capps will settle and convert into Orthofix common stock within 45 days after her termination of service with the company. Until then, they remain as deferred units representing a contingent right to receive common shares in the future.
What is Orthofix's Stock Purchase Plan and how did it affect Capps’ holdings?
Orthofix's Stock Purchase Plan is described as a "Stock Purchase Plan" under Rule 16b-3(b)(5), making share acquisitions exempt from Section 16(b). Under this plan, Vickie L. Capps previously acquired 750 shares on April 30, 2026, which are included in her 43,300 total direct and deferred holdings.
Is the Orthofix (OFIX) grant to Vickie L. Capps an open-market stock purchase?
No, the 14,965-unit transaction for Vickie L. Capps is a grant of deferred stock units at no cash price per share. It is classified as a grant or award acquisition rather than an open-market purchase, reflecting equity-based director compensation instead of a discretionary buy in the market.